查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1178009

虚拟临床试验的全球市场:各种实验设计，各适应症，各地区(2022年～2032年)

Global Virtual Clinical Trials Market by Study Design (Interventional, Observational, Expanded Access), by Indication (Oncology, Cardiovascular, Others), and by Region - 2022 to 2032
出版日期: | 出版商: Transparency Market Research | 英文 250 Pages | 商品交期: 2-10个工作天内

价格

本报告提供全球虚拟临床试验市场调查，提供市场概要，市场规模和预测，趋势，促进因素·阻碍因素，各种实验设计·各适应症·各地区的分析，及竞争情形等资讯。

目录

第1章 摘要整理

  • 全球市场预测
  • 需求面趋势
  • 供给面趋势
  • 技术蓝图分析
  • 分析与推荐事项

第2章 市场概要

  • 市场范围/分类法
  • 市场定义/范围/限制

第3章 市场背景

  • 市场动态
    • 促进因素
    • 阻碍因素
    • 机会
    • 趋势
  • 情势预测
    • 乐观情势下的需求
    • 在预计的情势的需求
    • 在保守的情势的需求
  • 机会地图分析
  • 供应链分析
  • 投资可行性矩阵
  • PESTLE和波特分析
  • 法规情形
    • 主要各地区
    • 各主要国家

第4章 全球虚拟临床试验市场分析(2017年～2021年)·预测(2022年～2032年)

  • 过去的市场规模，金额分析(2017年～2021年)
  • 现在及未来市场规模，金额预测(2022年～2032年)
    • 前一年同期比较成长趋势分析
    • 绝对的机会分析

第5章 全球虚拟临床试验市场分析(2017年～2021年)·预测(2022年～2032年):各种实验设计

  • 简介/主要调查结果
  • 过去的市场规模，金额分析，各种实验设计(2017年～2021年)
  • 现在及未来市场规模，金额的分析·预测，各种实验设计(2022年～2032年)
    • 干预实验
    • 观察实验
    • 扩张参加实验
  • 前一年同期比较成长趋势分析，各种实验设计(2017年～2021年)
  • 绝对的机会分析，各种实验设计(2022年～2032年)

第6章 全球虚拟临床试验市场分析(2017年～2021年)·预测(2022年～2032年):各适应症

  • 简介/主要调查结果
  • 过去的市场规模，金额分析，各适应症(2017年～2021年)
  • 现在及未来市场规模，金额分析·预测，各适应症(2022年～2032年)
    • 肿瘤
    • 循环系统
    • 其他
  • 前一年同期比较成长趋势分析，各适应症(2017年～2021年)
  • 绝对的机会分析，各适应症(2022年～2032年)

第7章 全球虚拟临床试验市场分析(2017年～2021年)·预测(2022年～2032年):各地区

  • 简介
  • 过去的市场规模，金额分析，各地区(2017年～2021年)
  • 目前市场规模，金额分析·预测，各地区(2022年～2032年)
    • 北美
    • 南美
    • 欧洲
    • 东亚
    • 南亚
    • 大洋洲
    • 中东·非洲
  • 市场魅力分析，各地区

第8章 北美的虚拟临床试验市场分析(2017年～2021年)·预测(2022年～2032年):各国

第9章 南美的虚拟临床试验市场分析(2017年～2021年)·预测(2022年～2032年):各国

第10章 欧洲的虚拟临床试验市场分析(2017年～2021年)·预测(2022年～2032年):各国

第11章 东亚的虚拟临床试验市场分析(2017年～2021年)·预测(2022年～2032年):各国

第12章 南亚的虚拟临床试验市场分析(2017年～2021年)·预测(2022年～2032年):各国

第13章 大洋洲的虚拟临床试验市场分析(2017年～2021年)·预测(2022年～2032年):各国

第14章 中东·非洲的虚拟临床试验市场分析(2017年～2021年)·预测(2022年～2032年):各国

第15章 主要国家的虚拟临床试验市场分析

  • 美国
    • 价格分析
    • 市场占有率分析，2021年
  • 加拿大
    • 价格分析
    • 市场占有率分析，2021年
  • 巴西
    • 价格分析
    • 市场占有率分析，2021年
  • 墨西哥
    • 价格分析
    • 市场占有率分析，2021年
  • 阿根廷
    • 价格分析
    • 市场占有率分析，2021年
  • 德国
    • 价格分析
    • 市场占有率分析，2021年
  • 义大利
    • 价格分析
    • 市场占有率分析，2021年
  • 法国
    • 价格分析
    • 市场占有率分析，2021年
  • 英国
    • 价格分析
    • 市场占有率分析，2021年
  • 西班牙
    • 价格分析
    • 市场占有率分析，2021年
  • 俄罗斯
    • 价格分析
    • 市场占有率分析，2021年
  • 荷比卢三国
    • 价格分析
    • 市场占有率分析，2021年
  • 中国
    • 价格分析
    • 市场占有率分析，2021年
  • 日本
    • 价格分析
    • 市场占有率分析，2021年
  • 韩国
    • 价格分析
    • 市场占有率分析，2021年
  • 印度
    • 价格分析
    • 市场占有率分析，2021年
  • 泰国
    • 价格分析
    • 市场占有率分析，2021年
  • 马来西亚
    • 价格分析
    • 市场占有率分析，2021年
  • 印尼
    • 价格分析
    • 市场占有率分析，2021年
  • 澳洲
    • 价格分析
    • 市场占有率分析，2021年
  • 纽西兰
    • 价格分析
    • 市场占有率分析，2021年
  • GCC各国
    • 价格分析
    • 市场占有率分析，2021年

第16章 市场结构分析

  • 竞争仪表板
  • 竞争基准
  • 主要企业的市场占有率分析
    • 各地区
    • 各种实验设计
    • 各适应症

第17章 竞争分析

  • 竞争详细内容
    • ICON, plc
    • Parexel International Corporation
    • IQVIA
    • Covance
    • PRA Health Sciences
    • LEO Innovation Lab
    • Medidata
    • Oracle
    • CRF Health
    • Clinical Ink
    • Medable, Inc.

第18章 前提条件与缩写的使用

第19章 调查手法

Product Code: TMRGL80368

TMR's report on the global virtual clinical trials market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global virtual clinical trials market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global virtual clinical trials market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the virtual clinical trials market.

The report delves into the competitive landscape of the global virtual clinical trials market. Key players operating in the global virtual clinical trials market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global virtual clinical trials market profiled in this report.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand-side Trends
  • 1.3. Supply-side Trends
  • 1.4. Technology Roadmap Analysis
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Background

  • 3.1. Market Dynamics
    • 3.1.1. Drivers
    • 3.1.2. Restraints
    • 3.1.3. Opportunity
    • 3.1.4. Trends
  • 3.2. Scenario Forecast
    • 3.2.1. Demand in Optimistic Scenario
    • 3.2.2. Demand in Likely Scenario
    • 3.2.3. Demand in Conservative Scenario
  • 3.3. Opportunity Map Analysis
  • 3.4. Supply Chain Analysis
  • 3.5. Investment Feasibility Matrix
  • 3.6. PESTLE and Porter's Analysis
  • 3.7. Regulatory Landscape
    • 3.7.1. By Key Regions
    • 3.7.2. By Key Countries

4. Global Virtual Clinical Trials Market Analysis 2017-2021 and Forecast, 2022-2032

  • 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
  • 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Global Virtual Clinical Trials Market Analysis 2017-2021 and Forecast 2022-2032, By Study Design

  • 5.1. Introduction / Key Findings
  • 5.2. Historical Market Size Value (US$ Mn) Analysis By Study Design, 2017-2021
  • 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Study Design, 2022-2032
    • 5.3.1. Interventional
    • 5.3.2. Observational
    • 5.3.3. Expanded Access
  • 5.4. Y-o-Y Growth Trend Analysis By Study Design, 2017-2021
  • 5.5. Absolute $ Opportunity Analysis By Study Design, 2022-2032

6. Global Virtual Clinical Trials Market Analysis 2017-2021 and Forecast 2022-2032, By Indication

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size Value (US$ Mn) Analysis By Indication, 2017-2021
  • 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Indication, 2022-2032
    • 6.3.1. Oncology
    • 6.3.2. Cardiovascular
    • 6.3.3. Others
  • 6.4. Y-o-Y Growth Trend Analysis By Indication, 2017-2021
  • 6.5. Absolute $ Opportunity Analysis By Indication, 2022-2032

7. Global Virtual Clinical Trials Market Analysis 2017-2021 and Forecast 2022-2032, By Region

  • 7.1. Introduction
  • 7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
  • 7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
    • 7.3.1. North America
    • 7.3.2. Latin America
    • 7.3.3. Europe
    • 7.3.4. East Asia
    • 7.3.5. South Asia
    • 7.3.6. Oceania
    • 7.3.7. MEA
  • 7.4. Market Attractiveness Analysis By Region

8. North America Virtual Clinical Trials Market Analysis 2017-2021 and Forecast 2022-2032, By Country

  • 8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  • 8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
    • 8.2.1. By Country
      • 8.2.1.1. U.S.
      • 8.2.1.2. Canada
    • 8.2.2. By Study Design
    • 8.2.3. By Indication
  • 8.3. Market Attractiveness Analysis
    • 8.3.1. By Country
    • 8.3.2. By Study Design
    • 8.3.3. By Indication
  • 8.4. Key Takeaways

9. Latin America Virtual Clinical Trials Market Analysis 2017-2021 and Forecast 2022-2032, By Country

  • 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  • 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
    • 9.2.1. By Country
      • 9.2.1.1. Brazil
      • 9.2.1.2. Mexico
      • 9.2.1.3. Argentina
      • 9.2.1.4. Rest of Latin America
    • 9.2.2. By Study Design
    • 9.2.3. By Indication
  • 9.3. Market Attractiveness Analysis
    • 9.3.1. By Country
    • 9.3.2. By Study Design
    • 9.3.3. By Indication
  • 9.4. Key Takeaways

10. Europe Virtual Clinical Trials Market Analysis 2017-2021 and Forecast 2022-2032, By Country

  • 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  • 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
    • 10.2.1. By Country
      • 10.2.1.1. Germany
      • 10.2.1.2. Italy
      • 10.2.1.3. France
      • 10.2.1.4. U.K.
      • 10.2.1.5. Spain
      • 10.2.1.6. Russia
      • 10.2.1.7. BENELUX
      • 10.2.1.8. Rest of Europe
    • 10.2.2. By Study Design
    • 10.2.3. By Indication
  • 10.3. Market Attractiveness Analysis
    • 10.3.1. By Country
    • 10.3.2. By Study Design
    • 10.3.3. By Indication
  • 10.4. Key Takeaways

11. East Asia Virtual Clinical Trials Market Analysis 2017-2021 and Forecast 2022-2032, By Country

  • 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  • 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
    • 11.2.1. By Country
      • 11.2.1.1. China
      • 11.2.1.2. Japan
      • 11.2.1.3. South Korea
    • 11.2.2. By Study Design
    • 11.2.3. By Indication
  • 11.3. Market Attractiveness Analysis
    • 11.3.1. By Country
    • 11.3.2. By Study Design
    • 11.3.3. By Indication
  • 11.4. Key Takeaways

12. South Asia Virtual Clinical Trials Market Analysis 2017-2021 and Forecast 2022-2032, By Country

  • 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  • 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
    • 12.2.1. By Country
      • 12.2.1.1. India
      • 12.2.1.2. Thailand
      • 12.2.1.3. Malaysia
      • 12.2.1.4. Indonesia
      • 12.2.1.5. Rest of South Asia
    • 12.2.2. By Study Design
    • 12.2.3. By Indication
  • 12.3. Market Attractiveness Analysis
    • 12.3.1. By Country
    • 12.3.2. By Study Design
    • 12.3.3. By Indication
  • 12.4. Key Takeaways

13. Oceania Virtual Clinical Trials Market Analysis 2017-2021 and Forecast 2022-2032, By Country

  • 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  • 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
    • 13.2.1. By Country
      • 13.2.1.1. Australia
      • 13.2.1.2. New Zealand
    • 13.2.2. By Study Design
    • 13.2.3. By Indication
  • 13.3. Market Attractiveness Analysis
    • 13.3.1. By Country
    • 13.3.2. By Study Design
    • 13.3.3. By Indication
  • 13.4. Key Takeaways

14. MEA Virtual Clinical Trials Market Analysis 2017-2021 and Forecast 2022-2032, By Country

  • 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  • 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
    • 14.2.1. By Country
      • 14.2.1.1. GCC
      • 14.2.1.2. Rest of MEA
    • 14.2.2. By Study Design
    • 14.2.3. By Indication
  • 14.3. Market Attractiveness Analysis
    • 14.3.1. By Country
    • 14.3.2. By Study Design
    • 14.3.3. By Indication
  • 14.4. Key Takeaways

15. Key Countries Virtual Clinical Trials Market Analysis

  • 15.1. U.S.
    • 15.1.1. Pricing Analysis
    • 15.1.2. Market Share Analysis, 2021
      • 15.1.2.1. By Study Design
      • 15.1.2.2. By Indication
  • 15.2. Canada
    • 15.2.1. Pricing Analysis
    • 15.2.2. Market Share Analysis, 2021
      • 15.2.2.1. By Study Design
      • 15.2.2.2. By Indication
  • 15.3. Brazil
    • 15.3.1. Pricing Analysis
    • 15.3.2. Market Share Analysis, 2021
      • 15.3.2.1. By Study Design
      • 15.3.2.2. By Indication
  • 15.4. Mexico
    • 15.4.1. Pricing Analysis
    • 15.4.2. Market Share Analysis, 2021
      • 15.4.2.1. By Study Design
      • 15.4.2.2. By Indication
  • 15.5. Argentina
    • 15.5.1. Pricing Analysis
    • 15.5.2. Market Share Analysis, 2021
      • 15.5.2.1. By Study Design
      • 15.5.2.2. By Indication
  • 15.6. Germany
    • 15.6.1. Pricing Analysis
    • 15.6.2. Market Share Analysis, 2021
      • 15.6.2.1. By Study Design
      • 15.6.2.2. By Indication
  • 15.7. Italy
    • 15.7.1. Pricing Analysis
    • 15.7.2. Market Share Analysis, 2021
      • 15.7.2.1. By Study Design
      • 15.7.2.2. By Indication
  • 15.8. France
    • 15.8.1. Pricing Analysis
    • 15.8.2. Market Share Analysis, 2021
      • 15.8.2.1. By Study Design
      • 15.8.2.2. By Indication
  • 15.9. U.K.
    • 15.9.1. Pricing Analysis
    • 15.9.2. Market Share Analysis, 2021
      • 15.9.2.1. By Study Design
      • 15.9.2.2. By Indication
  • 15.10. Spain
    • 15.10.1. Pricing Analysis
    • 15.10.2. Market Share Analysis, 2021
      • 15.10.2.1. By Study Design
      • 15.10.2.2. By Indication
  • 15.11. Russia
    • 15.11.1. Pricing Analysis
    • 15.11.2. Market Share Analysis, 2021
      • 15.11.2.1. By Study Design
      • 15.11.2.2. By Indication
  • 15.12. BENELUX
    • 15.12.1. Pricing Analysis
    • 15.12.2. Market Share Analysis, 2021
      • 15.12.2.1. By Study Design
      • 15.12.2.2. By Indication
  • 15.13. China
    • 15.13.1. Pricing Analysis
    • 15.13.2. Market Share Analysis, 2021
      • 15.13.2.1. By Study Design
      • 15.13.2.2. By Indication
  • 15.14. Japan
    • 15.14.1. Pricing Analysis
    • 15.14.2. Market Share Analysis, 2021
      • 15.14.2.1. By Study Design
      • 15.14.2.2. By Indication
  • 15.15. South Korea
    • 15.15.1. Pricing Analysis
    • 15.15.2. Market Share Analysis, 2021
      • 15.15.2.1. By Study Design
      • 15.15.2.2. By Indication
  • 15.16. India
    • 15.16.1. Pricing Analysis
    • 15.16.2. Market Share Analysis, 2021
      • 15.16.2.1. By Study Design
      • 15.16.2.2. By Indication
  • 15.17. Thailand
    • 15.17.1. Pricing Analysis
    • 15.17.2. Market Share Analysis, 2021
      • 15.17.2.1. By Study Design
      • 15.17.2.2. By Indication
  • 15.18. Malaysia
    • 15.18.1. Pricing Analysis
    • 15.18.2. Market Share Analysis, 2021
      • 15.18.2.1. By Study Design
      • 15.18.2.2. By Indication
  • 15.19. Indonesia
    • 15.19.1. Pricing Analysis
    • 15.19.2. Market Share Analysis, 2021
      • 15.19.2.1. By Study Design
      • 15.19.2.2. By Indication
  • 15.20. Australia
    • 15.20.1. Pricing Analysis
    • 15.20.2. Market Share Analysis, 2021
      • 15.20.2.1. By Study Design
      • 15.20.2.2. By Indication
  • 15.21. New Zealand
    • 15.21.1. Pricing Analysis
    • 15.21.2. Market Share Analysis, 2021
      • 15.21.2.1. By Study Design
      • 15.21.2.2. By Indication
  • 15.22. GCC Countries
    • 15.22.1. Pricing Analysis
    • 15.22.2. Market Share Analysis, 2021
      • 15.22.2.1. By Study Design
      • 15.22.2.2. By Indication

16. Market Structure Analysis

  • 16.1. Competition Dashboard
  • 16.2. Competition Benchmarking
  • 16.3. Market Share Analysis of Top Players
    • 16.3.1. By Regional
    • 16.3.2. By Study Design
    • 16.3.3. By Indication

17. Competition Analysis

  • 17.1. Competition Deep Dive
    • 17.1.1. ICON, plc
      • 17.1.1.1. Overview
      • 17.1.1.2. Product Portfolio
      • 17.1.1.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 17.1.1.4. Sales Footprint
      • 17.1.1.5. Strategy Overview
        • 17.1.1.5.1. Marketing Strategy
        • 17.1.1.5.2. Product Strategy
        • 17.1.1.5.3. Channel Strategy
    • 17.1.2. Parexel International Corporation
      • 17.1.2.1. Overview
      • 17.1.2.2. Product Portfolio
      • 17.1.2.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 17.1.2.4. Sales Footprint
      • 17.1.2.5. Strategy Overview
        • 17.1.2.5.1. Marketing Strategy
        • 17.1.2.5.2. Product Strategy
        • 17.1.2.5.3. Channel Strategy
    • 17.1.3. IQVIA
      • 17.1.3.1. Overview
      • 17.1.3.2. Product Portfolio
      • 17.1.3.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 17.1.3.4. Sales Footprint
      • 17.1.3.5. Strategy Overview
        • 17.1.3.5.1. Marketing Strategy
        • 17.1.3.5.2. Product Strategy
        • 17.1.3.5.3. Channel Strategy
    • 17.1.4. Covance
      • 17.1.4.1. Overview
      • 17.1.4.2. Product Portfolio
      • 17.1.4.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 17.1.4.4. Sales Footprint
      • 17.1.4.5. Strategy Overview
        • 17.1.4.5.1. Marketing Strategy
        • 17.1.4.5.2. Product Strategy
        • 17.1.4.5.3. Channel Strategy
    • 17.1.5. PRA Health Sciences
      • 17.1.5.1. Overview
      • 17.1.5.2. Product Portfolio
      • 17.1.5.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 17.1.5.4. Sales Footprint
      • 17.1.5.5. Strategy Overview
        • 17.1.5.5.1. Marketing Strategy
        • 17.1.5.5.2. Product Strategy
        • 17.1.5.5.3. Channel Strategy
    • 17.1.6. LEO Innovation Lab
      • 17.1.6.1. Overview
      • 17.1.6.2. Product Portfolio
      • 17.1.6.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 17.1.6.4. Sales Footprint
      • 17.1.6.5. Strategy Overview
        • 17.1.6.5.1. Marketing Strategy
        • 17.1.6.5.2. Product Strategy
        • 17.1.6.5.3. Channel Strategy
    • 17.1.7. Medidata
      • 17.1.7.1. Overview
      • 17.1.7.2. Product Portfolio
      • 17.1.7.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 17.1.7.4. Sales Footprint
      • 17.1.7.5. Strategy Overview
        • 17.1.7.5.1. Marketing Strategy
        • 17.1.7.5.2. Product Strategy
        • 17.1.7.5.3. Channel Strategy
    • 17.1.8. Oracle
      • 17.1.8.1. Overview
      • 17.1.8.2. Product Portfolio
      • 17.1.8.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 17.1.8.4. Sales Footprint
      • 17.1.8.5. Strategy Overview
        • 17.1.8.5.1. Marketing Strategy
        • 17.1.8.5.2. Product Strategy
        • 17.1.8.5.3. Channel Strategy
    • 17.1.9. CRF Health
      • 17.1.9.1. Overview
      • 17.1.9.2. Product Portfolio
      • 17.1.9.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 17.1.9.4. Sales Footprint
      • 17.1.9.5. Strategy Overview
        • 17.1.9.5.1. Marketing Strategy
        • 17.1.9.5.2. Product Strategy
        • 17.1.9.5.3. Channel Strategy
    • 17.1.10. Clinical Ink
      • 17.1.10.1. Overview
      • 17.1.10.2. Product Portfolio
      • 17.1.10.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 17.1.10.4. Sales Footprint
      • 17.1.10.5. Strategy Overview
        • 17.1.10.5.1. Marketing Strategy
        • 17.1.10.5.2. Product Strategy
        • 17.1.10.5.3. Channel Strategy
    • 17.1.11. Medable, Inc.
      • 17.1.11.1. Overview
      • 17.1.11.2. Product Portfolio
      • 17.1.11.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 17.1.11.4. Sales Footprint
      • 17.1.11.5. Strategy Overview
        • 17.1.11.5.1. Marketing Strategy
        • 17.1.11.5.2. Product Strategy
        • 17.1.11.5.3. Channel Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

List of Tables

  • Table 1: Global Virtual Clinical Trials Market Value (US$ Mn) Forecast by Region, 2017-2032
  • Table 2: Global Virtual Clinical Trials Market Value (US$ Mn) Forecast by Study Design, 2017-2032
  • Table 3: Global Virtual Clinical Trials Market Value (US$ Mn) Forecast by Indication, 2017-2032
  • Table 4: North America Virtual Clinical Trials Market Value (US$ Mn) Forecast by Country, 2017-2032
  • Table 5: North America Virtual Clinical Trials Market Value (US$ Mn) Forecast by Study Design, 2017-2032
  • Table 6: North America Virtual Clinical Trials Market Value (US$ Mn) Forecast by Indication, 2017-2032
  • Table 7: Latin America Virtual Clinical Trials Market Value (US$ Mn) Forecast by Country, 2017-2032
  • Table 8: Latin America Virtual Clinical Trials Market Value (US$ Mn) Forecast by Study Design, 2017-2032
  • Table 9: Latin America Virtual Clinical Trials Market Value (US$ Mn) Forecast by Indication, 2017-2032
  • Table 10: Europe Virtual Clinical Trials Market Value (US$ Mn) Forecast by Country, 2017-2032
  • Table 11: Europe Virtual Clinical Trials Market Value (US$ Mn) Forecast by Study Design, 2017-2032
  • Table 12: Europe Virtual Clinical Trials Market Value (US$ Mn) Forecast by Indication, 2017-2032
  • Table 13: East Asia Virtual Clinical Trials Market Value (US$ Mn) Forecast by Country, 2017-2032
  • Table 14: East Asia Virtual Clinical Trials Market Value (US$ Mn) Forecast by Study Design, 2017-2032
  • Table 15: East Asia Virtual Clinical Trials Market Value (US$ Mn) Forecast by Indication, 2017-2032
  • Table 16: South Asia Virtual Clinical Trials Market Value (US$ Mn) Forecast by Country, 2017-2032
  • Table 17: South Asia Virtual Clinical Trials Market Value (US$ Mn) Forecast by Study Design, 2017-2032
  • Table 18: South Asia Virtual Clinical Trials Market Value (US$ Mn) Forecast by Indication, 2017-2032
  • Table 19: Oceania Virtual Clinical Trials Market Value (US$ Mn) Forecast by Country, 2017-2032
  • Table 20: Oceania Virtual Clinical Trials Market Value (US$ Mn) Forecast by Study Design, 2017-2032
  • Table 21: Oceania Virtual Clinical Trials Market Value (US$ Mn) Forecast by Indication, 2017-2032
  • Table 22: MEA Virtual Clinical Trials Market Value (US$ Mn) Forecast by Country, 2017-2032
  • Table 23: MEA Virtual Clinical Trials Market Value (US$ Mn) Forecast by Study Design, 2017-2032
  • Table 24: MEA Virtual Clinical Trials Market Value (US$ Mn) Forecast by Indication, 2017-2032

List of Figure

  • Figure 1: Global Virtual Clinical Trials Market Value (US$ Mn) by Study Design, 2022-2032
  • Figure 2: Global Virtual Clinical Trials Market Value (US$ Mn) by Indication, 2022-2032
  • Figure 3: Global Virtual Clinical Trials Market Value (US$ Mn) by Region, 2022-2032
  • Figure 4: Global Virtual Clinical Trials Market Value (US$ Mn) Analysis by Region, 2017-2032
  • Figure 5: Global Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Region, 2022-2032
  • Figure 6: Global Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Region, 2022-2032
  • Figure 7: Global Virtual Clinical Trials Market Value (US$ Mn) Analysis by Study Design, 2017-2032
  • Figure 8: Global Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Study Design, 2022-2032
  • Figure 9: Global Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Study Design, 2022-2032
  • Figure 10: Global Virtual Clinical Trials Market Value (US$ Mn) Analysis by Indication, 2017-2032
  • Figure 11: Global Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Indication, 2022-2032
  • Figure 12: Global Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
  • Figure 13: Global Virtual Clinical Trials Market Attractiveness by Study Design, 2022-2032
  • Figure 14: Global Virtual Clinical Trials Market Attractiveness by Indication, 2022-2032
  • Figure 15: Global Virtual Clinical Trials Market Attractiveness by Region, 2022-2032
  • Figure 16: North America Virtual Clinical Trials Market Value (US$ Mn) by Study Design, 2022-2032
  • Figure 17: North America Virtual Clinical Trials Market Value (US$ Mn) by Indication, 2022-2032
  • Figure 18: North America Virtual Clinical Trials Market Value (US$ Mn) by Country, 2022-2032
  • Figure 19: North America Virtual Clinical Trials Market Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 20: North America Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Country, 2022-2032
  • Figure 21: North America Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Country, 2022-2032
  • Figure 22: North America Virtual Clinical Trials Market Value (US$ Mn) Analysis by Study Design, 2017-2032
  • Figure 23: North America Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Study Design, 2022-2032
  • Figure 24: North America Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Study Design, 2022-2032
  • Figure 25: North America Virtual Clinical Trials Market Value (US$ Mn) Analysis by Indication, 2017-2032
  • Figure 26: North America Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Indication, 2022-2032
  • Figure 27: North America Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
  • Figure 28: North America Virtual Clinical Trials Market Attractiveness by Study Design, 2022-2032
  • Figure 29: North America Virtual Clinical Trials Market Attractiveness by Indication, 2022-2032
  • Figure 30: North America Virtual Clinical Trials Market Attractiveness by Country, 2022-2032
  • Figure 31: Latin America Virtual Clinical Trials Market Value (US$ Mn) by Study Design, 2022-2032
  • Figure 32: Latin America Virtual Clinical Trials Market Value (US$ Mn) by Indication, 2022-2032
  • Figure 33: Latin America Virtual Clinical Trials Market Value (US$ Mn) by Country, 2022-2032
  • Figure 34: Latin America Virtual Clinical Trials Market Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 35: Latin America Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Country, 2022-2032
  • Figure 36: Latin America Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Country, 2022-2032
  • Figure 37: Latin America Virtual Clinical Trials Market Value (US$ Mn) Analysis by Study Design, 2017-2032
  • Figure 38: Latin America Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Study Design, 2022-2032
  • Figure 39: Latin America Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Study Design, 2022-2032
  • Figure 40: Latin America Virtual Clinical Trials Market Value (US$ Mn) Analysis by Indication, 2017-2032
  • Figure 41: Latin America Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Indication, 2022-2032
  • Figure 42: Latin America Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
  • Figure 43: Latin America Virtual Clinical Trials Market Attractiveness by Study Design, 2022-2032
  • Figure 44: Latin America Virtual Clinical Trials Market Attractiveness by Indication, 2022-2032
  • Figure 45: Latin America Virtual Clinical Trials Market Attractiveness by Country, 2022-2032
  • Figure 46: Europe Virtual Clinical Trials Market Value (US$ Mn) by Study Design, 2022-2032
  • Figure 47: Europe Virtual Clinical Trials Market Value (US$ Mn) by Indication, 2022-2032
  • Figure 48: Europe Virtual Clinical Trials Market Value (US$ Mn) by Country, 2022-2032
  • Figure 49: Europe Virtual Clinical Trials Market Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 50: Europe Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Country, 2022-2032
  • Figure 51: Europe Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Country, 2022-2032
  • Figure 52: Europe Virtual Clinical Trials Market Value (US$ Mn) Analysis by Study Design, 2017-2032
  • Figure 53: Europe Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Study Design, 2022-2032
  • Figure 54: Europe Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Study Design, 2022-2032
  • Figure 55: Europe Virtual Clinical Trials Market Value (US$ Mn) Analysis by Indication, 2017-2032
  • Figure 56: Europe Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Indication, 2022-2032
  • Figure 57: Europe Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
  • Figure 58: Europe Virtual Clinical Trials Market Attractiveness by Study Design, 2022-2032
  • Figure 59: Europe Virtual Clinical Trials Market Attractiveness by Indication, 2022-2032
  • Figure 60: Europe Virtual Clinical Trials Market Attractiveness by Country, 2022-2032
  • Figure 61: East Asia Virtual Clinical Trials Market Value (US$ Mn) by Study Design, 2022-2032
  • Figure 62: East Asia Virtual Clinical Trials Market Value (US$ Mn) by Indication, 2022-2032
  • Figure 63: East Asia Virtual Clinical Trials Market Value (US$ Mn) by Country, 2022-2032
  • Figure 64: East Asia Virtual Clinical Trials Market Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 65: East Asia Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Country, 2022-2032
  • Figure 66: East Asia Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Country, 2022-2032
  • Figure 67: East Asia Virtual Clinical Trials Market Value (US$ Mn) Analysis by Study Design, 2017-2032
  • Figure 68: East Asia Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Study Design, 2022-2032
  • Figure 69: East Asia Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Study Design, 2022-2032
  • Figure 70: East Asia Virtual Clinical Trials Market Value (US$ Mn) Analysis by Indication, 2017-2032
  • Figure 71: East Asia Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Indication, 2022-2032
  • Figure 72: East Asia Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
  • Figure 73: East Asia Virtual Clinical Trials Market Attractiveness by Study Design, 2022-2032
  • Figure 74: East Asia Virtual Clinical Trials Market Attractiveness by Indication, 2022-2032
  • Figure 75: East Asia Virtual Clinical Trials Market Attractiveness by Country, 2022-2032
  • Figure 76: South Asia Virtual Clinical Trials Market Value (US$ Mn) by Study Design, 2022-2032
  • Figure 77: South Asia Virtual Clinical Trials Market Value (US$ Mn) by Indication, 2022-2032
  • Figure 78: South Asia Virtual Clinical Trials Market Value (US$ Mn) by Country, 2022-2032
  • Figure 79: South Asia Virtual Clinical Trials Market Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 80: South Asia Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Country, 2022-2032
  • Figure 81: South Asia Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Country, 2022-2032
  • Figure 82: South Asia Virtual Clinical Trials Market Value (US$ Mn) Analysis by Study Design, 2017-2032
  • Figure 83: South Asia Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Study Design, 2022-2032
  • Figure 84: South Asia Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Study Design, 2022-2032
  • Figure 85: South Asia Virtual Clinical Trials Market Value (US$ Mn) Analysis by Indication, 2017-2032
  • Figure 86: South Asia Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Indication, 2022-2032
  • Figure 87: South Asia Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
  • Figure 88: South Asia Virtual Clinical Trials Market Attractiveness by Study Design, 2022-2032
  • Figure 89: South Asia Virtual Clinical Trials Market Attractiveness by Indication, 2022-2032
  • Figure 90: South Asia Virtual Clinical Trials Market Attractiveness by Country, 2022-2032
  • Figure 91: Oceania Virtual Clinical Trials Market Value (US$ Mn) by Study Design, 2022-2032
  • Figure 92: Oceania Virtual Clinical Trials Market Value (US$ Mn) by Indication, 2022-2032
  • Figure 93: Oceania Virtual Clinical Trials Market Value (US$ Mn) by Country, 2022-2032
  • Figure 94: Oceania Virtual Clinical Trials Market Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 95: Oceania Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Country, 2022-2032
  • Figure 96: Oceania Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Country, 2022-2032
  • Figure 97: Oceania Virtual Clinical Trials Market Value (US$ Mn) Analysis by Study Design, 2017-2032
  • Figure 98: Oceania Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Study Design, 2022-2032
  • Figure 99: Oceania Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Study Design, 2022-2032
  • Figure 100: Oceania Virtual Clinical Trials Market Value (US$ Mn) Analysis by Indication, 2017-2032
  • Figure 101: Oceania Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Indication, 2022-2032
  • Figure 102: Oceania Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
  • Figure 103: Oceania Virtual Clinical Trials Market Attractiveness by Study Design, 2022-2032
  • Figure 104: Oceania Virtual Clinical Trials Market Attractiveness by Indication, 2022-2032
  • Figure 105: Oceania Virtual Clinical Trials Market Attractiveness by Country, 2022-2032
  • Figure 106: MEA Virtual Clinical Trials Market Value (US$ Mn) by Study Design, 2022-2032
  • Figure 107: MEA Virtual Clinical Trials Market Value (US$ Mn) by Indication, 2022-2032
  • Figure 108: MEA Virtual Clinical Trials Market Value (US$ Mn) by Country, 2022-2032
  • Figure 109: MEA Virtual Clinical Trials Market Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 110: MEA Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Country, 2022-2032
  • Figure 111: MEA Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Country, 2022-2032
  • Figure 112: MEA Virtual Clinical Trials Market Value (US$ Mn) Analysis by Study Design, 2017-2032
  • Figure 113: MEA Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Study Design, 2022-2032
  • Figure 114: MEA Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Study Design, 2022-2032
  • Figure 115: MEA Virtual Clinical Trials Market Value (US$ Mn) Analysis by Indication, 2017-2032
  • Figure 116: MEA Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Indication, 2022-2032
  • Figure 117: MEA Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
  • Figure 118: MEA Virtual Clinical Trials Market Attractiveness by Study Design, 2022-2032
  • Figure 119: MEA Virtual Clinical Trials Market Attractiveness by Indication, 2022-2032
  • Figure 120: MEA Virtual Clinical Trials Market Attractiveness by Country, 2022-2032